 SARASOTA, Fla., March 11, 2021 PRNewswire -- INVO Bioscience, Inc. NASDAQ: INVO, a medical device company focused on commercializing the worlds only in vivo Intravaginal Culture System IVC, INVOcell, an effective and affordable treatment for patients diagnosed with infertility, today announced it will participate in the 33rd Annual ROTH Conference, which will be held virtually from March 15-17, 2021. 